PRMT5-MTA-IN-3
PRMT5-MTA-IN-3 (Compound P2A) is an orally active and selective protein arginine methyltransferase 5 (PRMT5) inhibitor. PRMT5-MTA-IN-3 inhibits cell proliferation in the MTAP-deficient colorectal cancer HCT - 116 cell line with an IC50 value of 5 nM. PRMT5-MTA-IN-3 is promising for research of cancers, especially for MTAP-deficient tumors, such as colorectal cancer, non-small cell lung cancer, pancreatic cancer[1].
Product Specifications
CAS Number
3028674-29-2
UNSPSC
12352211
Target
Histone Methyltransferase
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CN1N=CC2=C1C(N)=NC=C2NC(C(N([C@@H]3COC4=CC(C(F)(F)F)=CC=C43)C)=O)=O
Molecular Formula
C19H17F3N6O3
Molecular Weight
434.37
References & Citations
[1]Liu B, et al. Prmt5-mta inhibitor. WO2024152973A1. 2024-07-25.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
1- (4-Hydrazinylpiperidin-1-yl) ethan-1-one dihydrochloride
